Astrana Health, Inc. (ASTH)
USD 31.08
(-4.95%)
USD 31.08
(-4.95%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 112.59 Million USD | 36.9% |
| 2022 | 95.21 Million USD | 19.62% |
| 2021 | 79.59 Million USD | 409.6% |
| 2020 | 15.61 Million USD | -61.07% |
| 2019 | 40.11 Million USD | -15.08% |
| 2018 | 47.24 Million USD | 78.69% |
| 2017 | 26.43 Million USD | 0.0% |
| 2015 | 16.27 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 38.72 Million USD | -9.64% |
| 2024 Q2 | 35.95 Million USD | -7.15% |
| 2023 Q1 | 25.47 Million USD | 4.21% |
| 2023 Q4 | 42.85 Million USD | 27.1% |
| 2023 Q2 | 28.3 Million USD | 11.11% |
| 2023 Q3 | 33.71 Million USD | 19.12% |
| 2023 FY | 130.34 Million USD | 36.9% |
| 2022 Q2 | 19.89 Million USD | 66.57% |
| 2022 FY | 95.21 Million USD | 19.62% |
| 2022 Q4 | 24.44 Million USD | 14.3% |
| 2022 Q3 | 21.38 Million USD | 7.51% |
| 2022 Q1 | 11.94 Million USD | -28.06% |
| 2021 Q4 | 16.6 Million USD | -23.89% |
| 2021 Q2 | 14.19 Million USD | 0.0% |
| 2021 Q3 | 21.81 Million USD | 53.62% |
| 2021 FY | 79.59 Million USD | 409.6% |
| 2020 FY | 15.61 Million USD | -61.07% |
| 2019 FY | 40.11 Million USD | -15.08% |
| 2018 FY | 47.24 Million USD | 78.69% |
| 2017 FY | 26.43 Million USD | 0.0% |
| 2015 FY | 16.27 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | 36.029% |
| Addus HomeCare Corporation | 248.92 Million USD | 54.766% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | 4.838% |
| Amedisys, Inc. | 834.47 Million USD | 86.507% |
| American Oncology Network, Inc. | 83.97 Million USD | -34.084% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 80.83% |
| IMAC Holdings, Inc. | 5.02 Million USD | -2139.789% |
| biote Corp. | 98.82 Million USD | -13.935% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -219.829% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | 66.657% |
| COMPASS Pathways plc | 136.91 Million USD | 17.764% |
| DocGo Inc. | 180.32 Million USD | 37.56% |
| The Ensign Group, Inc. | 335.39 Million USD | 66.428% |
| Healthcare Services Group, Inc. | 189.09 Million USD | 40.454% |
| InnovAge Holding Corp. | 558.25 Million USD | 79.831% |
| Assure Holdings Corp. | 15.43 Million USD | -629.302% |
| The Joint Corp. | 109.22 Million USD | -3.089% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 77.079% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -517.236% |
| ModivCare Inc. | 586.89 Million USD | 80.815% |
| NewGenIvf Group Limited | 1.63 Million USD | -6767.584% |
| Novo Integrated Sciences, Inc. | 13.5 Million USD | -733.689% |
| Option Care Health, Inc. | 666.62 Million USD | 83.109% |
| P3 Health Partners Inc. | 199.56 Million USD | 43.579% |
| P3 Health Partners Inc. | 199.56 Million USD | 43.579% |
| The Pennant Group, Inc. | 88.99 Million USD | -26.521% |
| Surgery Partners, Inc. | 319.5 Million USD | 64.758% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -2518.84% |
| Talkspace, Inc. | 97.58 Million USD | -15.379% |
| Talkspace, Inc. | 97.58 Million USD | -15.379% |
| The Oncology Institute, Inc. | 136.59 Million USD | 17.566% |
| The Oncology Institute, Inc. | 136.59 Million USD | 17.566% |